Electromed (NYSE:ELMD) Downgraded by StockNews.com

StockNews.com lowered shares of Electromed (NYSE:ELMD) from a strong-buy rating to a buy rating in a research note released on Thursday morning.

Separately, TheStreet raised shares of Electromed from a c+ rating to a b- rating in a research note on Wednesday, February 21st.

Electromed Price Performance

Shares of ELMD opened at $13.94 on Thursday. Electromed has a 1-year low of $8.80 and a 1-year high of $17.85. The stock has a market cap of $120.02 million, a PE ratio of 30.98 and a beta of 0.43. The firm has a 50-day simple moving average of $15.25 and a two-hundred day simple moving average of $12.10.

Electromed (NYSE:ELMD) last released its quarterly earnings data on Tuesday, February 13th. The company reported $0.19 earnings per share for the quarter. Electromed had a net margin of 7.62% and a return on equity of 10.32%. The company had revenue of $13.69 million for the quarter.

Institutional Investors Weigh In On Electromed

Several institutional investors have recently made changes to their positions in ELMD. Cetera Advisor Networks LLC purchased a new stake in shares of Electromed during the 2nd quarter worth $129,000. State Street Corp boosted its position in shares of Electromed by 8.3% during the 2nd quarter. State Street Corp now owns 15,736 shares of the company’s stock worth $152,000 after purchasing an additional 1,207 shares in the last quarter. BlackRock Inc. boosted its position in shares of Electromed by 7.6% during the 2nd quarter. BlackRock Inc. now owns 20,521 shares of the company’s stock worth $220,000 after purchasing an additional 1,452 shares in the last quarter. Gabelli Funds LLC boosted its position in shares of Electromed by 17.3% in the 4th quarter. Gabelli Funds LLC now owns 20,367 shares of the company’s stock worth $222,000 after buying an additional 3,000 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Electromed by 4.7% in the 2nd quarter. Northern Trust Corp now owns 29,078 shares of the company’s stock worth $311,000 after buying an additional 1,306 shares in the last quarter. 40.82% of the stock is currently owned by hedge funds and other institutional investors.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.